E-LIB Suche - Ergebnisse für: Doe, Christopher

1

Ergonomics in IR:

Knuttinen, Martha-Gracia ; Zurcher, Kenneth S. ; Wallace, Alex...
Journal of Vascular and Interventional Radiology. 32 (2021) 2 - p. 235-241 , 2021

Link: https://doi.org/10.1016/..

2

In vitro and in vivo preclinical profile of abediterol (LAS..:

Aparici, Mònica ; Gavaldà, Amadeu ; Ramos, Israel...
European Journal of Pharmacology. 770 (2016) - p. 61-69 , 2016

Link: https://doi.org/10.1016/..

3

Assessment of respiratory function and duration of action i..:

Montero, Jose L. ; Doe, Christopher ; Miralpeix, Montserrat.
Journal of Pharmacological and Toxicological Methods. 66 (2012) 2 - p. 161-162 , 2012

Link: https://doi.org/10.1016/..

4

Statin-Induced Rhabdomyolysis Associated With Transjugular ..:

Swei, Eric C. ; Brar, Anantnoor K. ; Rice, Jonathan D....
ACG Case Reports Journal. 9 (2022) 5 - p. e00774 , 2022

Link: https://doi.org/10.14309..

5

Biphenyl/diphenyl ether renin inhibitors: Filling the S1 po..:

Yuan, Jing ; Simpson, Robert D. ; Zhao, Wei...
Bioorganic & Medicinal Chemistry Letters. 21 (2011) 16 - p. 4836-4843 , 2011

Link: https://doi.org/10.1016/..

6

Discovery of VTP-27999, an Alkyl Amine Renin Inhibitor with..:

Jia, Lanqi ; Simpson, Robert D. ; Yuan, Jing...
ACS Medicinal Chemistry Letters. 2 (2011) 10 - p. 747-751 , 2011

Link: https://doi.org/10.1021/..

7

Optimization of orally bioavailable alkyl amine renin inhib..:

Xu, Zhenrong ; Cacatian, Salvacion ; Yuan, Jing...
Bioorganic & Medicinal Chemistry Letters. 20 (2010) 2 - p. 694-699 , 2010

Link: https://doi.org/10.1016/..

8

Potent, Selective and Orally Bioavailable Dihydropyrimidine..:

Sehon, Clark A. ; Wang, Gren Z. ; Viet, Andrew Q....
Journal of Medicinal Chemistry. 51 (2008) 21 - p. 6631-6634 , 2008

Link: https://doi.org/10.1021/..

9

Development of Dihydropyridone Indazole Amides as Selective..:

Goodman, Krista B. ; Cui, Haifeng ; Dowdell, Sarah E....
Journal of Medicinal Chemistry. 50 (2006) 1 - p. 6-9 , 2006

Link: https://doi.org/10.1021/..

10

The peptidic urotensin‐II receptor ligand GSK248451 possess..:

Behm, David J ; Stankus, Gerald ; Doe, Christopher P A...
British Journal of Pharmacology. 148 (2006) 2 - p. 173-190 , 2006

Link: https://doi.org/10.1038/..

11

Discovery of Aminofurazan-azabenzimidazoles as Inhibitors o..:

Stavenger, Robert A. ; Cui, Haifeng ; Dowdell, Sarah E....
Journal of Medicinal Chemistry. 50 (2006) 1 - p. 2-5 , 2006

Link: https://doi.org/10.1021/..

12

Synthetic LXR agonists increase LDL in CETP species:

Groot, Pieter H.E. ; Pearce, Nigel J. ; Yates, John W....
Journal of Lipid Research. 46 (2005) 10 - p. 2182-2191 , 2005

Link: https://doi.org/10.1194/..

13

Urotensin-II: a novel systemic hypertensive factor in the c..:

Maniscalco, Kristeen ; Stankus, Gerald P. ; Wibberley, Alexandra...
Naunyn-Schmiedeberg's Archives of Pharmacology. 369 (2004) 3 - p. 274-280 , 2004

Link: https://doi.org/10.1007/..

14

Deletion of the UT receptor gene results in the selective l..:

Behm, David J ; Harrison, Stephen M ; Ao, Zhaohui...
British Journal of Pharmacology. 139 (2003) 2 - p. 464-472 , 2003

Link: https://doi.org/10.1038/..

15

A method for QT correction based on beat-to-beat analysis o..:

Batey, Andrew J. ; Doe, Christopher P.A.
Journal of Pharmacological and Toxicological Methods. 48 (2002) 1 - p. 11-19 , 2002

Link: https://doi.org/10.1016/..